Balance Sheet Indivior PLC

Equities

INDV

GB00BN4HT335

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:01 18/09/2024 BST			5-day change	1st Jan Change
725.50 ^GBX	-0.34%		+1.04%	-38.78%

09-05	Transcript : Indivior PLC Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM
09-04	Indivior reports "disappointing" results for study with Aelis Farma	AN

b7c2950d165f9327f4325b6ee4.-QL-9PfGnyAhJeOUUB2o3ApcLeDcbTjkJBOA794PoY4.qXKfq773rHNYFKLGBHLL8UAESIidO27Qc3G0i5JlxLu8e83BhJnYEXlytg

Published financial data: INDIVIOR PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	785M	647M	791M	901M	1.09B
Total Revenues	785M	647M	791M	901M	1.09B
Cost of Goods Sold, Total	140M	92M	127M	159M	186M
Gross Profit	645M	555M	664M	742M	907M
Selling General & Admin Expenses, Total	390M	427M	425M	461M	543M
R&D Expenses	53M	40M	52M	72M	106M
Other Operating Expenses	-	-	-	-3M	-2M
Other Operating Expenses, Total	443M	467M	477M	530M	647M
Operating Income	202M	88M	187M	212M	260M
Interest Expense, Total	-20M	-17M	-18M	-22M	-30M
Interest And Investment Income	24M	7M	1M	18M	43M
Net Interest Expenses	4M	-10M	-17M	-4M	13M
Other Non Operating Income (Expenses)	-	0	3M	1M	-1M
EBT, Excl. Unusual Items	206M	78M	173M	209M	272M
Restructuring Charges	-20M	-11M	1M	-	-
Gain (Loss) On Sale Of Assets	-	-	20M	-	-
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	12M	5M	1M
Legal Settlements	-10M	-235M	-14M	-303M	-247M
Other Unusual Items	4M	-5M	-2M	-6M	-25M
EBT, Incl. Unusual Items	180M	-173M	190M	-95M	1M
Income Tax Expense	46M	-25M	-15M	-42M	-1M
Earnings From Continuing Operations	134M	-148M	205M	-53M	2M
Net Income to Company	134M	-148M	205M	-53M	2M
Net Income - (IS)	134M	-148M	205M	-53M	2M
Net Income to Common Incl Extra Items	134M	-148M	205M	-53M	2M
Net Income to Common Excl. Extra Items	134M	-148M	205M	-53M	2M
Per Share Items
Net EPS - Basic	0.92	-1.01	1.41	-0.38	0.01
Basic EPS - Continuing Operations	0.92	-1.01	1.41	-0.38	0.01
Basic Weighted Average Shares Outstanding	146M	147M	146M	139M	137M
Net EPS - Diluted	0.9	-1.01	1.35	-0.38	0.01
Diluted EPS - Continuing Operations	0.9	-1.01	1.35	-0.38	0.01
Diluted Weighted Average Shares Outstanding	151M	147M	154M	139M	142M
Normalized Basic EPS	0.88	0.33	0.74	0.94	1.24
Normalized Diluted EPS	0.85	0.33	0.7	0.94	1.2
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	214M	101M	199M	223M	269M
EBITA	207M	94M	193M	217M	262M
EBIT	202M	88M	187M	212M	260M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	25.56	14.45	-7.89	44.21	-100
Total Current Taxes	38M	8M	3M	64M	55M
Total Deferred Taxes	8M	-33M	-18M	-106M	-56M
Normalized Net Income	129M	48.75M	108M	131M	170M
Interest on Long-Term Debt	3M	3M	2M	2M	3M
Non-Cash Pension Expense	-	1M	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	53M	40M	52M	72M	106M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	3M	8M	11M	16M	22M
Total Stock-Based Compensation	3M	8M	11M	16M	22M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	1.06B	858M	1.1B	774M	316M
Short Term Investments	-	-	-	109M	84M
Trading Asset Securities, Total	-	-	-	10M	10M
Total Cash And Short Term Investments	1.06B	858M	1.1B	893M	410M
Accounts Receivable, Total	192M	179M	202M	220M	254M
Other Receivables	12M	7M	13M	5M	-
Total Receivables	204M	186M	215M	225M	254M
Inventory	73M	93M	95M	114M	142M
Prepaid Expenses	23M	17M	18M	14M	23M
Other Current Assets, Total	-	33M	14M	13M	434M
Total Current Assets	1.36B	1.19B	1.44B	1.26B	1.26B
Gross Property Plant And Equipment	175M	171M	169M	162M	198M
Accumulated Depreciation	-68M	-68M	-74M	-77M	-81M
Net Property Plant And Equipment	107M	103M	95M	85M	117M
Long-term Investments	-	-	-	98M	41M
Goodwill	-	-	-	-	5M
Other Intangibles, Total	72M	62M	82M	70M	232M
Deferred Tax Assets Long-Term	40M	75M	105M	219M	268M
Other Long-Term Assets, Total	73M	104M	106M	38M	28M
Total Assets	1.65B	1.53B	1.83B	1.77B	1.95B
Liabilities
Accounts Payable, Total	39M	20M	137M	36M	39M
Accrued Expenses, Total	124M	108M	147M	581M	704M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	4M	4M	3M	3M	3M
Current Portion of Leases	5M	8M	8M	8M	9M
Current Income Taxes Payable	39M	15M	7M	9M	18M
Other Current Liabilities	531M	444M	502M	382M	532M
Total Current Liabilities	742M	599M	804M	1.02B	1.3B
Long-Term Debt	233M	230M	239M	237M	236M
Long-Term Leases	51M	43M	36M	29M	34M
Pension & Other Post Retirement Benefits	3M	4M	3M	-	-
Other Non Current Liabilities	414M	573M	547M	433M	379M
Total Liabilities	1.44B	1.45B	1.63B	1.72B	1.95B
Common Stock, Total	73M	73M	70M	68M	68M
Additional Paid In Capital	5M	6M	7M	8M	11M
Retained Earnings	1.45B	1.31B	1.44B	1.3B	1.24B
Comprehensive Income and Other	-1.32B	-1.31B	-1.31B	-1.33B	-1.32B
Total Common Equity	209M	82M	203M	51M	0
Total Equity	209M	82M	203M	51M	0
Total Liabilities And Equity	1.65B	1.53B	1.83B	1.77B	1.95B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	146M	147M	140M	136M	136M
ECS Total Common Shares Outstanding	146M	147M	140M	136M	137M
Book Value / Share	1.43	0.56	1.44	0.37	0
Tangible Book Value	137M	20M	121M	-19M	-237M
Tangible Book Value Per Share	0.94	0.14	0.86	-0.14	-1.74
Total Debt	293M	285M	286M	277M	282M
Net Debt	-767M	-573M	-816M	-616M	-128M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	28M	38M	34M	27M	38M
Inventories - Work In Process, Total	22M	19M	28M	42M	34M
Inventories - Finished Goods, Total	23M	36M	33M	45M	70M
Land - (BS)	54M	55M	55M	51M	69M
Machinery, Total	66M	73M	77M	80M	96M
Full Time Employees	796	788	885	928	1.16K
Accumulated Allowance for Doubtful Accounts (Supple)	2M	2M	3M	2M	2M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	134M	-148M	205M	-53M	2M
Depreciation & Amortization - CF	15M	15M	13M	14M	16M
Amortization of Goodwill and Intangible Assets - (CF)	5M	6M	6M	5M	2M
Depreciation & Amortization, Total	20M	21M	19M	19M	18M
Amortization of Deferred Charges, Total - (CF)	8M	5M	3M	2M	10M
(Gain) Loss From Sale Of Asset	-4M	-2M	-20M	-1M	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	3M	8M	11M	16M	22M
Other Operating Activities, Total	69M	-58M	-38M	-112M	-62M
Change In Accounts Receivable	62M	15M	-25M	-21M	-33M
Change In Inventories	7M	-16M	-3M	-25M	-21M
Change In Accounts Payable	-101M	-103M	201M	-98M	115M
Change in Other Net Operating Assets	-47M	85M	0	269M	-366M
Cash from Operations	151M	-193M	353M	-4M	-315M
Capital Expenditure	-7M	-4M	-4M	-5M	-8M
Cash Acquisitions	-	-	-	-	-129M
Sale (Purchase) of Intangible assets	4M	-	-10M	0	-45M
Investment in Marketable and Equity Securities, Total	-	-	-	-218M	84M
Other Investing Activities, Total	1M	-	-	-	-
Cash from Investing	-2M	-4M	-14M	-223M	-98M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	250M	-	-
Total Debt Issued	-	-	250M	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-13M	-11M	-244M	-12M	-20M
Total Debt Repaid	-13M	-11M	-244M	-12M	-20M
Issuance of Common Stock	-	1M	1M	2M	4M
Repurchase of Common Stock	-	-	-101M	-90M	-33M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	3M
Cash from Financing	-13M	-10M	-94M	-100M	-46M
Foreign Exchange Rate Adjustments	-	5M	-1M	-1M	1M
Net Change in Cash	136M	-202M	244M	-328M	-458M
Supplemental Items
Cash Interest Paid	17M	20M	18M	24M	32M
Cash Income Tax Paid (Refund)	-18M	34M	17M	57M	33M
Levered Free Cash Flow	166M	-101M	318M	342M	-61.25M
Unlevered Free Cash Flow	178M	-90M	329M	356M	-42.5M
Change In Net Working Capital	-24M	175M	-193M	-191M	202M
Net Debt Issued / Repaid	-13M	-11M	6M	-12M	-20M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	7.89	3.46	6.95	7.36	8.73
Return on Total Capital	31.21	12.66	27.31	32.44	53.28
Return On Equity %	97.45	-101.72	143.86	-41.73	7.84
Return on Common Equity	97.45	-101.72	143.86	-41.73	7.84
Margin Analysis
Gross Profit Margin %	82.17	85.78	83.94	82.35	82.98
SG&A Margin	49.68	66	53.73	51.17	49.68
EBITDA Margin %	27.26	15.61	25.16	24.75	24.61
EBITA Margin %	26.37	14.53	24.4	24.08	23.97
EBIT Margin %	25.73	13.6	23.64	23.53	23.79
Income From Continuing Operations Margin %	17.07	-22.87	25.92	-5.88	0.18
Net Income Margin %	17.07	-22.87	25.92	-5.88	0.18
Net Avail. For Common Margin %	17.07	-22.87	25.92	-5.88	0.18
Normalized Net Income Margin	16.4	7.53	13.67	14.5	15.55
Levered Free Cash Flow Margin	21.11	-15.55	40.15	37.93	-5.6
Unlevered Free Cash Flow Margin	22.71	-13.91	41.58	39.46	-3.89
Asset Turnover
Asset Turnover	0.49	0.41	0.47	0.5	0.59
Fixed Assets Turnover	9.57	6.16	7.99	10.01	10.82
Receivables Turnover (Average Receivables)	3.41	3.49	4.15	4.27	4.61
Inventory Turnover (Average Inventory)	1.85	1.11	1.35	1.52	1.45
Short Term Liquidity
Current Ratio	1.83	1.98	1.8	1.24	0.97
Quick Ratio	1.7	1.74	1.64	1.1	0.51
Operating Cash Flow to Current Liabilities	0.2	-0.32	0.44	-0	-0.24
Days Sales Outstanding (Average Receivables)	107.17	104.93	87.9	85.48	79.14
Days Outstanding Inventory (Average Inventory)	196.84	330.2	270.16	239.89	251.18
Average Days Payable Outstanding	116.26	96.4	222.11	177.37	61.4
Cash Conversion Cycle (Average Days)	187.75	338.73	135.95	147.99	268.93
Long Term Solvency
Total Debt/Equity	140.19	347.56	140.89	543.14	-
Total Debt / Total Capital	58.37	77.66	58.49	84.45	100
LT Debt/Equity	135.89	332.93	135.47	521.57	-
Long-Term Debt / Total Capital	56.57	74.39	56.24	81.1	95.74
Total Liabilities / Total Assets	87.35	94.64	88.92	97.12	100
EBIT / Interest Expense	10.1	5.18	10.39	9.64	8.67
EBITDA / Interest Expense